[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Instructions for Authors::
Instructions for Reviewers::
Checklists::
Articles archive::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 9, Issue 1 (5-2025) ::
jhgg 2025, 9(1): 0-0 Back to browse issues page
Bridging Genetics and Diagnosis in Type 1 and Type 2 Diabetes: The Role of Polymorphisms
Darya Taromi Rezaie , Ameneh Mohammadi , Fereshteh Atabi * , Mahdi Moassesfar
Abstract:   (6 Views)
Diabetes mellitus, encompassing type 1 (T1D) and type 2 diabetes (T2D), is a major global health burden with rapidly increasing prevalence. T1D is characterized by autoimmune destruction of pancreatic β-cells, whereas T2D primarily involves insulin resistance and β-cell dysfunction. Despite advances in clinical and molecular research, gaps remain in understanding the genetic architecture and gene–environment interactions driving disease onset and progression. This review summarizes current evidence on genetic polymorphisms associated with T1D and T2D, with a focus on their roles in disease susceptibility, complications, and potential therapeutic implications. In T1D, variants in the HLA region, INS, and PTPN22 have been strongly linked to autoimmunity and β-cell vulnerability. In T2D, genes such as TCF7L2, KCNJ11, SLC30A8, and EPO influence insulin secretion, glucose homeostasis, and risk modulation, with loss-of-function mutations in SLC30A8 showing protective effects. Emerging data highlight how genetic variants interact with zinc metabolism, inflammatory pathways, and environmental factors to shape disease heterogeneity. Additionally, polymorphisms in both T1D- and T2D-associated genes contribute to the risk of long-term complications, including nephropathy, retinopathy, and cardiovascular disease. By integrating evidence from genome-wide association studies, next-generation sequencing, and functional analyses, this review emphasizes the diagnostic and prognostic value of genetic markers. Understanding these genetic insights not only enhances risk prediction and early diagnosis but also supports the development of precision medicine approaches tailored to individual genetic backgrounds.
 
Keywords: Polymorphism, Genetic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Precision Medicine.
Full-Text [PDF 273 kb]   (3 Downloads)    
Type of Study: Review | Subject: Human Genetics
Received: 2026/01/10 | Accepted: 2026/04/7 | Published: 2025/05/30
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: 0



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Taromi Rezaie D, Mohammadi A, Atabi F, Moassesfar M. Bridging Genetics and Diagnosis in Type 1 and Type 2 Diabetes: The Role of Polymorphisms. jhgg 2025; 9 (1)
URL: http://humangeneticsgenomics.ir/article-1-122-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 9, Issue 1 (5-2025) Back to browse issues page
Journal of Human Genetics and Genomics Journal of Human Genetics and Genomics
Persian site map - English site map - Created in 0.11 seconds with 37 queries by YEKTAWEB 4758